The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
LEUKEMIA
Authors: Schleussner, Nikolai; Merkel, Olaf; Costanza, Mariantonia; Liang, Huan-Chang; Hummel, Franziska; Romagnani, Chiara; Durek, Pawel; Anagnostopoulos, Ioannis; Hummel, Michael; Joehrens, Korinna; Niedobitek, Antonia; Griffin, Patrick R.; Piva, Roberto; Sczakiel, Henrike L.; Woessmann, Wilhelm; Damm-Welk, Christine; Hinze, Christian; Stoiber, Dagmar; Gillissen, Bernd; Turner, Suzanne D.; Kaergel, Eva; von Hoff, Linda; Grau, Michael; Lenz, Georg; Doerken, Bernd; Scheidereit, Claus; Kenner, Lukas; Janz, Martin; Mathas, Stephan
Abstract
Transcription factor AP-1 is constitutively activated and IRF4 drives growth and survival in ALK(+) and ALK(+) anaplastic large cell lymphoma (ALCL). Here we demonstrate high-level BA IF and BA IF3 expression in ALCL. Both BATFs bind classical AP-1 motifs and interact with in ALCL deregulated AP-1 factors. Together with IRF4, they co-occupy AP-1-IRF composite elements, differentiating ALCL from non-ALCL. Gene-specific inactivation of BATFs, or global AP-1 inhibition results in ALCL growth retardation and/or cell death in vitro and in vivo. Furthermore, the AP-1-BATF module establishes TH17/group 3 innate lymphoid cells (ILC3)-associated gene expression in ALCL cells, including marker genes such as AHR, IL17F, IL22, IL26, IL23R and ROR gamma t. Elevated IL-17A and IL-17F levels were detected in a subset of children and adolescents with ALK(+) ALCL. Furthermore, a comprehensive analysis of primary lymphoma data confirms TH17(-), and in particular ILC3-skewing in ALCL compared with PTCL. Finally, pharmacological inhibition of RORC as single treatment leads to cell death in ALCL cell lines and, in combination with the ALK inhibitor crizotinib, enforces death induction in ALK(+) ALCL. Our data highlight the crucial role of AP-1/BATFs in ALCL and lead to the concept that some ALCL might originate from ILC3.
The Non-synonymous rs763780 Single-Nucleotide Polymorphism in IL17F Gene Is Associated With Susceptibility to Tuberculosis and Advanced Disease Severity in Argentina
FRONTIERS IN IMMUNOLOGY
Authors: Rolandelli, Agustin; Pellegrini, Joaquin Miguel; Hernandez Del Pino, Rodrigo Emanuel; Liliana Tateosian, Nancy; Oscar Amiano, Nicolas; Paula Morelli, Maria; Andrea Castello, Florencia; Casco, Nicolas; Levi, Alberto; Juan Palmero, Domingo; Edith Garcia, Veronica
Abstract
Th17 lymphocytes, that produce IL17A, IL17F, and IL22, play a crucial role during the immune response against Mycobacterium tuberculosis (Mtb) infection. Whereas, the contribution of IL17A in immunity to tuberculosis is usually accepted, the role of IL17F has been scarcely studied so far. The aim of this work was to evaluate the existence of a potential association of the non-synonymous variant rs763780 SNP of the IL17F gene with human tuberculosis. Accordingly, by comparing healthy donors (HD) and tuberculosis patients (TB) populations we demonstrated an association between the C allele of the SNP and the susceptibility to tuberculosis disease in Argentina. Furthermore, we found that peripheral blood mononuclear cells (PBMCs) from individuals with a more effective immune response against Mtb secreted the highest levels of IL17F when stimulated with a lysate of Mtb (Mtb-Ag). Besides, we evidenced that Mtb-Ag-stimulated PBMCs from HD carrying the C variant of the SNP displayed the lowest IFNG secretion, proliferation index, and SLAM expression as compared to TT carriers. Moreover, Mtb-Ag-stimulated PBMCs from TB carrying the C allele produced the lowest levels of IFNG, the highest level of IL17A, and the minimum proliferation indexes as compared to TT TB, suggesting a relationship between the C allele and tuberculosis severity. In fact, TB carrying the C allele presented a more severe disease, with the highest bacilli burden in sputum. Together, our findings identify the IL17F rs763780 SNP as a biomarker of tuberculosis susceptibility and advanced disease severity in Argentina, suggesting that IL17F could be a critical cytokine in tuberculosis immunity.